• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE FLEX; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE FLEX; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PED-475-25
Device Problem Activation Failure (3270)
Patient Problem Fistula (1862)
Event Date 10/23/2018
Event Type  Injury  
Manufacturer Narrative
The pipeline flex was not returned for analysis; therefore, no definitive conclusion can be drawn regarding the clinical observation.However, the device is pending return.Upon receipt of the device a supplemental report will be filed.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during treatment of cerebral aneurysm with a medtronic flow diversion device, it did not open at the proximal end.The physician stated that the internal carotid-cave 15 mm blood vessel distal to the aneurysm was tortuous.Prior to the reported event, the medtronic guide catheter was advanced until it could go no further (distal of the aneurysm), and then they started to deploy the flow diversion device.The medtronic flow diversion device opened up several mm from the tip of the flow diversion device, but it did not open at the proximal end despite several attempts at deploying it.As the physician decided to discontinue the attempts, the patient complained about pain.Also, during the angiography with contrast, a carotid cavernous fistula (ccf) was found, so they stopped using the reported product.The vessel was severely tortuous.The procedure was not completed.After that procedure, coiling therapy was carried out with tve, but the condition did not recover, and an operation was performed the other day.It was reported that the patient¿s condition was stable.
 
Manufacturer Narrative
Type of report: additional information.Follow-up type: additional information.Device evaluation: device returned.The pipeline flex was returned for evaluation.As received, the device was within the catheter.For further examination, the pipeline flex was pushed out from the catheter with no issue.The distal and proximal dps restraints were found to be intact.The dps sleeves were found intact with no signs of damage.The distal hypotube and ptfe shrink tubing were found to be intact with no signs of elongation.The distal and proximal ends of the pipeline flex braid fully opened and severely frayed.No bend was found on the pushwire.No damages were found with the tip coil, distal marker, re-sheathing marker, re-sheathing pad or with the proximal bumper.No other anomalies were observed.Based the analysis findings, the customer report of ¿failure to open at the proximal end¿ could not be confirmed.The event cause could not be determined as the distal and proximal ends of the returned pipeline flex braid appeared fully opened and severely frayed.The damage on both ends of the pipeline flex braid is likely the result of the customer re-sheathing the device more than recommended two times.It is possible that the "severe vessel tortuosity" and "damaged braid" may have contributed to the reported issue.All products are 100% inspected for damages and irregularities during manufacture.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE FLEX
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
MDR Report Key8061873
MDR Text Key126922482
Report Number2029214-2018-00935
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
PMA/PMN Number
P100018.S011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/11/2021
Device Model NumberPED-475-25
Device Lot NumberA628385
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/20/2018
Initial Date Manufacturer Received 10/23/2018
Initial Date FDA Received11/12/2018
Supplement Dates Manufacturer Received01/24/2019
Supplement Dates FDA Received02/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-